Clinical trials
Terminated Observational trials in Hong Kong
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 2 |
| 2014 | 2 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 3 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 21 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Chinese University of Hong Kong | 9 |
| AstraZeneca | 2 |
| The University of Hong Kong | 2 |
| Abbott Medical Devices | 1 |
| Boston Scientific Corporation | 1 |
| Gilead Sciences | 1 |
| Humanity & Health Medical Group Limited | 1 |
| Queen Mary Hospital, Hong Kong | 1 |
| Takeda | 1 |
| University of Washington | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Crohn Disease | 2 |
| Diabetes Mellitus, Type 2 | 2 |
| Heart Diseases | 2 |
| Acute Coronary Syndrome | 1 |
| Atrial Fibrillation | 1 |
| Breast Neoplasms | 1 |
| Bundle-Branch Block | 1 |
| COVID-19 | 1 |
| Carcinoma, Hepatocellular | 1 |
| Cardiac Conduction System Disease | 1 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.